Welcome to our dedicated page for Precision Optics Corporation news (Ticker: $POCI), a resource for investors and traders seeking the latest updates and insights on Precision Optics Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Precision Optics Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Precision Optics Corporation's position in the market.
Rhea-AI Summary
Precision Optics , Inc. (NASDAQ: POCI) has announced the receipt of a $1.25 million follow-on production order from a major U.S. defense contractor for a highly complex optical assembly. The order is expected to be delivered over the next 6 to 12 months, with the customer showing increased internal demand for the product. This order signifies a strong relationship between Precision Optics and the defense contractor, highlighting the company's innovative capabilities in micro-optics for defense applications.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.8%
Tags
-
Rhea-AI Summary
Precision Optics , Inc. (POCI) will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on May 1, 2024, and holding 1x1 meetings on May 2, 2024. Dr. Joe Forkey, CEO, and Wayne Coll, CFO, will be presenting at the conference. The presentation can be accessed via webcast on the company's website. In-person meetings can be arranged with management by contacting Planet MicroCap or Lytham Partners.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.54%
Tags
-
Rhea-AI Summary
Precision Optics , Inc. (NASDAQ: POCI) has announced the receipt of a $720,000 follow-on production order from a top-tier defense/aerospace customer for a new optical application. This order adds to the initial $680,000 production order received in September 2023, and $517,000 in follow-on orders in November and December 2023, bringing the total production orders for this application to over $1.9 million. The company's innovative optical assembly has met high-performance requirements, leading to multiple follow-on orders expected to be delivered by August 2024. CEO Dr. Joe Forkey expressed confidence in strong revenue growth for fiscal year 2024 and anticipated continued order volumes for the next fiscal year and beyond, signaling expansion in the defense and aerospace market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) reported Q2 2024 financial results with an 18% revenue decrease to $4.8 million, a net loss of ($758,802), and adjusted EBITDA of ($269,034). The company saw a 33% increase in engineering revenue and signed production agreements with major medical device and surgical robotics companies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
-
Rhea-AI Summary
Precision Optics Corporation, Inc. (Nasdaq: POCI) has scheduled a conference call to discuss its second quarter of fiscal year 2024 financial results. The call will take place on Wednesday, February 14, 2024, at 5:00pm ET. Interested parties can access the call through dial-in information or a live webcast. The Company intends to release its financial results and file its 10-Q after the close of the market on the same day, followed by the conference call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) announced CEO Dr. Joe Forkey's participation in the Lytham Partners 2024 Investor Select Conference. The company will host a webcasted fireside chat and one-on-one meetings with investors. The webcast will be available for replay, and investors can arrange meetings with management via Lytham Partners.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.82%
Tags
Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) has signed a production and technology license agreement with a leading surgical robotics company to supply a single-use endoscope assembly for their cystoscopy robotic surgery system. The agreement reflects the successful joint product development initiatives and leverages POC's unique micro-optics and digital imaging technologies. Production is set to begin at POC's facilities in the next six to twelve months, with potential transfer to the customer's or a third-party manufacturer's facilities in the future. The market for single-use medical devices is growing rapidly, and POC is well-positioned to capitalize on this trend.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2%
Tags
-
Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) announced the receipt of initial purchase orders towards a $1.4 million total program development project to develop a highly complex imaging sub-assembly for a next generation ophthalmoscope for a major medical device company. The initial purchase orders amount to $170,000 towards the development budget and the program is expected to move to initial production in 18 months. The new device aims to improve access to high-quality retinal exams, crucial for early detection of diabetic retinopathy and other treatable retina-based conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.3%
Tags
-
Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) announced unaudited Q1 2024 operating results, revealing a 15% revenue decrease to $4.3 million. The company also reported a net loss of ($464,415) and an adjusted EBITDA of ($244,983) for the quarter. Recent highlights include a $890,000 production order for a new robotic laparoscopy system and a $680,000 production order for a defense/aerospace application.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.5%
Tags
News
Rhea-AI Summary
Precision Optics Corporation, Inc. (NASDAQ: POCI) announced an $890,000 initial production order for a complex imaging sub-assembly for a new robotic laparoscopy system. The order is expected to be delivered between January and October 2024, with potential for follow-on orders depending on market acceptance. This development is anticipated to drive revenue growth and recovery in the second half of the fiscal year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.06%
Tags
Precision Optics Corporation, Inc.
Nasdaq:POCI
POCI Rankings
POCI Stock Data
34.23M
3.57M
25.87%
26.65%
0.14%
Surgical and Medical Instrument Manufacturing
Manufacturing
United States of America
GARDNER